Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Filings indexed 1,778 across all filing types
Latest filing 2013-11-15 Declaration of Voting R…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details a notification received pursuant to Article 26, Section 1 of the WpHG (German Securities Trading Act) regarding Morgan Stanley exceeding a voting rights threshold (5%) in Evotec AG. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements'.
2013-11-15 English
Declaration of Voting Results & Voting Rights Announcements 2013
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details a notification received according to Article 26, Section 1 of the WpHG (German Securities Trading Act). It specifically states that a shareholder's voting rights have fallen below a certain threshold (3%). This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements'.
2013-11-15 English
Investor Presentation 2013
Investor Presentation Classification · 99% confidence The document text contains detailed financial figures for '9M/2013' (Nine Months 2013), including revenues, operating loss, liquidity, and management guidance for the full year 2013. It also includes comparative historical data (2009-2012) and forward-looking estimates (2013E, 2014E) in a tabular format. The content focuses on periodic financial performance review and outlook, which strongly suggests a quarterly or interim report. Since the period covered is '9M/2013', this aligns perfectly with the definition of an Interim/Quarterly Report (IR). It is not a full Annual Report (10-K), an Earnings Release (ER, which is usually just the highlights), or a Call Transcript (CT). The presence of detailed financial tables and performance analysis confirms it is the comprehensive report itself, not just an announcement of one (RPA/RNS).
2013-11-15 English
Evotec AG reports first nine months 2013 results
Earnings Release Classification · 100% confidence The document explicitly states that Evotec AG is reporting 'financial results and corporate updates for the third quarter and first nine months of 2013 ending 30 September 2013.' It provides detailed financial figures (revenues, operating loss, liquidity) for the nine-month period and confirms financial guidance for the full year 2013. This content structure—reporting results for a period shorter than a year (nine months) with detailed financial performance metrics—is characteristic of an Interim/Quarterly Report (IR). It is not a full Annual Report (10-K), an Earnings Release (ER) which is usually just highlights, nor a Call Transcript (CT). Since the document contains the comprehensive results for the period, it is classified as IR. 9M 2013
2013-11-12 English
Evotec AG, Q3 2013 Präsentation
Investor Presentation Classification · 98% confidence The document text contains several key indicators: 1. The title mentions "Nine-month report 2013". 2. The content is structured like a presentation, with sections like "Agenda", "Highlights nine months 2013", and detailed slides discussing business updates, financial performance, and strategy. 3. It explicitly discusses financial figures for the first nine months of 2013 (€ 60.3 m) and Q3 2013. 4. The structure strongly suggests an Investor Presentation (IP) or a document accompanying an earnings/interim report discussion, rather than the full, formal regulatory report itself (like an IR or 10-K). Since it is a presentation summarizing nine-month results, 'Investor Presentation' (IP) is the most appropriate classification, as it is a detailed document for investors summarizing performance and outlook, distinct from a brief Earnings Release (ER) or a comprehensive Interim Report (IR).
2013-11-12 English
Q3 Report 2013
Management Reports Classification · 99% confidence The document is titled "Management report of the first nine months of 2013" and contains detailed financial figures (revenues, operating loss, liquidity), operational performance summaries, strategic updates (EVT Execute, EVT Integrate, EVT Innovate), and guidance for the full year 2013. This structure, covering a period shorter than a full year (nine months) with comprehensive financial and operational details, strongly indicates an Interim/Quarterly Report. It is not a brief announcement (RPA/RNS) because the text is extensive (85,019 characters) and contains the full substance of the report, not just a notice of publication. It is too detailed to be just an Earnings Release (ER) which usually contains only key highlights. Therefore, the most appropriate classification is Interim / Quarterly Report (IR).
2013-11-12 German

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.